Review Policy
Acta Pharma Reports Journal uses double-blind review, in which the identity of both the reviewer and the author are unknown to each other. This ensures impartiality and helps every paper get an unbiased review.
Model of Double Blind Peer Review
TIMING – Pre-Prints
IDENTIFIABILITY – Double blind
MEDIATION – Editors mediate all Reviewers interactions between reviewers and authors
PUBLICATION – Peer reviews are not published
FACILITATION – Review facilitated by a journal
OWNERSHIP – Review owned by a journal or third party